Preclinical molecule development is a essential step in bringing groundbreaking therapies to patients. Enhancing the potency of these therapies requires detailed understanding of their pharmacokinetic (PK) and pharmacodynamic (PD) properties. Comprehensive preclinical DMPK services offer a broad range of studies designed to characterize the fate a